Ferroptosis, a newly identified form of oxidative cell death that is genetically, biochemically, and morphologically distinct from necrosis, autophagy, and apoptosis [12], has been recently reported to be involved in CRC progression [13], even emerging as a therapeutic strategy to trigger KRAS mutant CRC cell death [14]. This evidence concerns the gene KRAS and colorectal carcinoma.